title: Mefloquine-induced acute hepatitis.
abstract: Mefloquine is an effective drug for prophylaxis and treatment of malaria caused by Plasmodium falciparum. It is generally well tolerated with few side effects. Minimal elevation of liver function tests has been reported after exposure to mefloquine, especially in susceptible individuals with prior abnormal liver function tests. Our patient, who had had elevated liver function tests attributed to heart failure, experienced an acute elevation of liver transaminases 6 weeks after exposure to mefloquine 250 mg/week. Cessation of the drug caused test results to return to normal. Mefloquine should be prescribed cautiously in patients with liver disease.
authors.affiliation: Department of Medicine, Hadassah University Hospital, Hebrew University, Hadassah Medical School, Jerusalem, Israel.
authors.forename: I
authors.initials: I
authors.lastname: Gotsman
authors.forename: T
authors.initials: T
authors.lastname: Azaz-Livshits
authors.forename: Z
authors.initials: Z
authors.lastname: Fridlender
authors.forename: M
authors.initials: M
authors.lastname: Muszkat
authors.forename: E
authors.initials: E
authors.lastname: Ben-Chetrit
mesh_terms: D000208:Acute Disease; D000368:Aged; D000962:Antimalarials / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D022781:Hepatocytes / Q000187:drug effects / Q000473:pathology; D006801:Humans; D008297:Male; D015767:Mefloquine / Q000009:adverse effects*
chemical_list: D000962:Antimalarials; D015767:Mefloquine